- Home
- IVVD vs CSLR Comparison
IVVD vs CSLR Comparison
Compare IVVD & CSLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVVD
- CSLR
- Stock Information
- Founded
- IVVD 2020
- CSLR 2022
- Country
- IVVD United States
- CSLR United States
- Employees
- IVVD N/A
- CSLR N/A
- Industry
- IVVD Biotechnology: Pharmaceutical Preparations
- CSLR Semiconductors
- Sector
- IVVD Health Care
- CSLR Technology
- Exchange
- IVVD Nasdaq
- CSLR Nasdaq
- Market Cap
- IVVD 123.8M
- CSLR 118.0M
- IPO Year
- IVVD 2021
- CSLR N/A
- Fundamental
- Price
- IVVD $0.51
- CSLR $1.95
- Analyst Decision
- IVVD Strong Buy
- CSLR Buy
- Analyst Count
- IVVD 3
- CSLR 2
- Target Price
- IVVD $7.52
- CSLR $6.00
- AVG Volume (30 Days)
- IVVD 1.7M
- CSLR 531.2K
- Earning Date
- IVVD 05-08-2025
- CSLR 04-23-2025
- Dividend Yield
- IVVD N/A
- CSLR N/A
- EPS Growth
- IVVD N/A
- CSLR N/A
- EPS
- IVVD N/A
- CSLR N/A
- Revenue
- IVVD $25,384,000.00
- CSLR $40,797,000.00
- Revenue This Year
- IVVD $606.63
- CSLR $12.07
- Revenue Next Year
- IVVD $83.30
- CSLR $254.23
- P/E Ratio
- IVVD N/A
- CSLR N/A
- Revenue Growth
- IVVD N/A
- CSLR N/A
- 52 Week Low
- IVVD $0.36
- CSLR $0.20
- 52 Week High
- IVVD $2.74
- CSLR $3.37
- Technical
- Relative Strength Index (RSI)
- IVVD 38.07
- CSLR 65.24
- Support Level
- IVVD $0.46
- CSLR $1.36
- Resistance Level
- IVVD $0.56
- CSLR $1.63
- Average True Range (ATR)
- IVVD 0.06
- CSLR 0.17
- MACD
- IVVD 0.01
- CSLR 0.05
- Stochastic Oscillator
- IVVD 29.24
- CSLR 93.33
About IVVD Invivyd Inc.
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.
About CSLR Complete Solaria Inc.
Complete Solaria Inc is a solar company with unique technology and end-to-end customer offering, which includes financing, project fulfilment and customer service. Complete Solaria's digital platform together with premium solar products enable one-stop service for clean energy needs for customers wishing to make the transition to a more energy-efficient lifestyle.